Risks and mitigation strategies to prevent etoposide infusion-related reactions in children.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 8, p. 700, doi. 10.1002/phar.2603
- By:
- Publication type:
- Article
Works matching IS 02770008 AND DT 2021 AND VI 41 AND IP 8
Results: 7
1
2
Therapeutic review of cabotegravir/rilpivirine long-acting antiretroviral injectable and implementation considerations at an HIV specialty clinic.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 8, p. 686, doi. 10.1002/phar.2605
- By:
- Publication type:
- Article
3
Optimizing rapid diagnostics and diagnostic stewardship in Gram-negative bacteremia.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 8, p. 676, doi. 10.1002/phar.2606
- By:
- Publication type:
- Article
4
The immunomodulatory effects of opioids and implications for intensive care unit populations.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 8, p. 668, doi. 10.1002/phar.2602
- By:
- Publication type:
- Article
5
Outcomes of adult patients in the intensive care unit with Pseudomonas aeruginosa pneumonia who received an active anti-pseudomonal β-lactam: Does "S" equal success in the presence of resistance to other anti-pseudomonal β-lactams?
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 8, p. 658, doi. 10.1002/phar.2600
- By:
- Publication type:
- Article
6
Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 8, p. 649, doi. 10.1002/phar.2601
- By:
- Publication type:
- Article
7
Administration of rabies immunoglobulin: Improving evidence-based guidance for wound infiltration.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 8, p. 644, doi. 10.1002/phar.2604
- By:
- Publication type:
- Article